Genefitletics
PrivateLast Round
Pre Seed
Apr 24, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genefitletics operates in Healthcare & Life Sciences and is based in Delhi. Its latest recorded funding round was a Pre Seed round in April 2023.
Genefitletics is a healthcare technology company that provides a platform using multi-omics and machine learning for the early detection of degenerative diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genefitletics Comparables
Compare Genefitletics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MicrobioTx | 82% | |
| Leucine Rich Bio | 82% | |
| Iom Bioworks | 79% |
For institutional investors. Book with your work email.
Genefitletics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genefitletics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IIM Udaipur Incubation Centre | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 35% MoM, reaching 1K.
- Oct 27, 2025
Developing a molecular digital twin and personalized health investigator platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 22, 2026
Genefitletics officially launches Prognora, an AI-powered prognostic platform that detects molecular and microbial abnormalities up to 7 to 10 years before clinical diagnosis, with direct-to-consumer and healthcare-practitioner availability from Oct 26th '26.
For institutional investors. Book with your work email.
Genefitletics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genefitletics's valuation, stock price, and market status.
Is Genefitletics a public or private company?
Genefitletics is a private company.
What is the current stock price of Genefitletics?
Genefitletics is a private company, so its shares have no public market price. Caplight tracks Genefitletics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genefitletics worth (valuation)?
Valuation information for Genefitletics is not publicly available.
Can I buy Genefitletics stock?
Genefitletics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genefitletics's last funding round?
Genefitletics's most recent funding round was Pre Seed on April 24, 2023.
Who are the main investors in Genefitletics?
Key investors in Genefitletics include IIM Udaipur Incubation Centre.
Will Genefitletics IPO soon?
No public IPO plans have been announced for Genefitletics.
How can I track Genefitletics secondary market activity?
Caplight tracks bids, offers, and trades in Genefitletics's shares on secondary markets.